INDEGENE
|
The Current P/B Ratio of INDEGENE is 4.57.
| Share Price | ₹489.0 | Apr 16,2026 |
| Market Cap | ₹11,778.8 Cr | |
| Book Value | ₹2,579.5 Cr | Mar2025 - Consolidated Results |
| Price/Book | 4.57x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹11,778.8 Cr] as on Apr 16,2026
(/) Book Value [ ₹2,579.5 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 4.57x ]
Thus, for INDEGENE , the investors are currently willing to pay '4.57 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.07x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2025 at 5.37x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| INDEGENE | 2,579.50 | 4.57 | 11,778.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.63 | 406,243.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.17 | 167,179.0 |
| CIPLA LTD | 31,079.30 | 3.20 | 99,417.9 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 18.53 | 140,670.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.05 | 101,932.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.08 | 86,888.0 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.95 | 94,505.5 |
| LUPIN LTD | 17,119.50 | 6.21 | 106,363.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.47 | 80,504.9 |
| ABBOTT INDIA LTD | 4,204.27 | 13.07 | 54,955.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.47x |
| Max industry PB | 18.53x |
| Median industry PB | 5.63x |
| Average industry PB | 7.08x |
You may also like the below Video Courses